AGM Statement and Capital Markets Day
6 November 2018 – Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 1pm. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:
“We have experienced a positive start to trading in the first four months of the year, in line with management expectations. Strong demand has continued across our enlarged product suite, from both new and existing customers.
“Our recent Financial Performance Summit in the US was the most well attended in the history of the Company, with representatives from approximately 600 hospitals. From the workshops and panel discussions at the event, it is evident that the move to value-based care is growing in momentum and hospitals are preparing for this shift. As we launch our new Trisus products over the coming weeks and continue to invest in future products over the coming years, we see the opportunity for Craneware to become a major player in the healthcare market, ensuring hospitals have the tools to thrive in this near era, improving both margins and patient outcomes.
“With a continued high level of recurring revenues, a growing customer base, healthy cash balances and significantly increased addressable market through our expanding product suite, we look to the future with confidence.”
Capital Markets Day
Craneware is holding a Capital Markets Day for institutional investors and analysts this morning at 9am in the offices of Peel Hunt in London. The presentations will discuss the evolution of the US healthcare market and provide further insight into Craneware’s newly launched Trisus products, including Trisus Healthcare Intelligence. Keith Neilson, CEO, and Craig Preston, CFO, will be joined by other members of the Craneware Board and senior leadership team. No further update on trading will be provided.
Presentation materials will be made available on the Company’s website at www.craneware.com.
For further information, please contact:
Keith Neilson, CEO / Craig Preston, CFO
|+44 (0) 131 550 3100|
|Peel Hunt (NOMAD and Joint Broker)|
Dan Webster / George Sellar
|+44 (0) 20 7418 8900|
|Investec Bank (Joint Broker)|
Patrick Robb/ Sebastian Lawrence / Henry Reast
|+44 (0) 20 7597 5970
|Alma (Financial PR)|
Caroline Forde/ Robyn Fisher / Josh Royston
|+44 (0) 7779 664 584|
Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.
Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware’s market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
Learn more at www.craneware.com.
You might also like...
Dec 21, 2018 | Announcements
Strong performance expected to deliver revenue and adjusted EBITDA growth in the range of 15% to 20% 21 December 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, notes the recent...read more
Nov 9, 2018 | Announcements
09 November 2018 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018. For those shareholders...read more